205 related articles for article (PubMed ID: 16835012)
1. Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
Morgan ML; Cook IA; Rapkin AJ; Leuchter AF
Maturitas; 2007 Jan; 56(1):54-60. PubMed ID: 16835012
[TBL] [Abstract][Full Text] [Related]
2. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study.
Morgan ML; Cook IA; Rapkin AJ; Leuchter AF
J Clin Psychiatry; 2005 Jun; 66(6):774-80. PubMed ID: 15960574
[TBL] [Abstract][Full Text] [Related]
3. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center.
Seritan AL; Iosif AM; Park JH; DeatherageHand D; Sweet RL; Gold EB
Menopause; 2010 Mar; 17(2):410-5. PubMed ID: 20216277
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.
Ladd CO; Newport DJ; Ragan KA; Loughhead A; Stowe ZN
Depress Anxiety; 2005; 22(2):94-7. PubMed ID: 16094663
[TBL] [Abstract][Full Text] [Related]
5. Estrogen replacement therapy for depression in perimenopausal women.
Shaukat A; Arain TM; Shahid A; Irfan S; Farrukh S
J Coll Physicians Surg Pak; 2005 Oct; 15(10):597-600. PubMed ID: 19810294
[TBL] [Abstract][Full Text] [Related]
6. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
Bares M; Brunovsky M; Kopecek M; Stopkova P; Novak T; Kozeny J; Höschl C
J Psychiatr Res; 2007; 41(3-4):319-25. PubMed ID: 16889798
[TBL] [Abstract][Full Text] [Related]
7. QEEG changes during switch from depression to hypomania/mania: a case report.
Kopecek M; Tislerova B; Sos P; Bares M; Novak T; Krajca V; Brunovsky M
Neuro Endocrinol Lett; 2008 Jun; 29(3):295-302. PubMed ID: 18580843
[TBL] [Abstract][Full Text] [Related]
8. Depression and the menopause: why antidepressants are not enough?
Graziottin A; Serafini A
Menopause Int; 2009 Jun; 15(2):76-81. PubMed ID: 19465674
[TBL] [Abstract][Full Text] [Related]
9. Escitalopram for perimenopausal depression: an open-label pilot study.
Freeman MP; Hill R; Brumbach BH
J Womens Health (Larchmt); 2006 Sep; 15(7):857-61. PubMed ID: 16999641
[TBL] [Abstract][Full Text] [Related]
10. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
Inan I; Kelekci S; Yilmaz B
Gynecol Endocrinol; 2005 Feb; 20(2):64-7. PubMed ID: 15823823
[TBL] [Abstract][Full Text] [Related]
11. [Mood disorders in perimenopausal women: hormone replacement or antidepressant therapy?].
Bertschy G; De Ziegler D; Bianchi-Demicheli F
Rev Med Suisse; 2005 Sep; 1(33):2155-6, 2159-61. PubMed ID: 16223218
[TBL] [Abstract][Full Text] [Related]
12. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
13. The risk factors and symptomatology of perimenopausal depression.
Oztürk O; Eraslan D; Mete HE; Ozşener S
Maturitas; 2006 Sep; 55(2):180-6. PubMed ID: 16581210
[TBL] [Abstract][Full Text] [Related]
14. Depression, the perimenopause, and estrogen therapy.
Schmidt PJ
Ann N Y Acad Sci; 2005 Jun; 1052():27-40. PubMed ID: 16024748
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of different antidepression therapy in perimenopausal and postmenopausal women with depression].
Lai AL; Zhao YW; Qi HY; Zhang JS; Zhang LS; Weng YQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):169-72. PubMed ID: 17537301
[TBL] [Abstract][Full Text] [Related]
16. Perimenopausal postpartum depression after conception by assisted reproductive technology.
McIntosh MD; Ferrando S
Psychosomatics; 2010; 51(4):345-8. PubMed ID: 20587765
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
Soares CN; Arsenio H; Joffe H; Bankier B; Cassano P; Petrillo LF; Cohen LS
Menopause; 2006; 13(5):780-6. PubMed ID: 16894334
[TBL] [Abstract][Full Text] [Related]
18. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review.
Toffol E; Heikinheimo O; Partonen T
Menopause; 2015 May; 22(5):564-78. PubMed ID: 25203891
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.
Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN;
Menopause; 2018 Oct; 25(10):1069-1085. PubMed ID: 30179986
[TBL] [Abstract][Full Text] [Related]
20. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
